Midatech Pharma Share Discussion Threads

[tomboyb] 13/12/2022 15:45

Maybe a trade at these levels to 4p -

[zen12] 13/12/2022 15:44

Certainly wanting to AIM with as money as they can lol

[tomboyb] 13/12/2022 15:43

Well, from 98 million shares to 247 mill shares and 645million warrants -

Hefty -

[tomboyb] 13/12/2022 15:30

3.3p placing as well -

hmm -

[tomboyb] 13/12/2022 15:28

Aim cancellation and hefty dilution -

[tomboyb] 13/12/2022 15:25

13 December 2022

Midatech Pharma PLC

("Midatech" or the "Company")

Proposed Acquisition of Bioasis Technologies Inc.

Equity Raise of US$10.0 million

Change of Name to Biodexa Pharmaceuticals PLC

Company to Remain Listed on NASDAQ; Proposed Cancellation of Admission to Trading on AIM

and General Meeting

[daniel] 28/10/2022 09:40

Criticalthinker1, any new findings on your investigations?

[criticalthinker1] 26/9/2022 19:28

Waiting for the bang. Softly softly...

[criticalthinker1] 18/9/2022 19:03

I'm reading more into this re Parker and his links to obviously sareum but also fidelity management galapagos GSK and physiomics...and a Belgian hnwi investor in sareum
Wheels within wheels.
I continue with the digging

[criticalthinker1] 14/9/2022 15:13

Just added 800 pounds but had to pay 12.9p!

[criticalthinker1] 14/9/2022 14:54

So Mr Parker is undertaking a consolidation. Slightly concerning given that the BOD at Sareum said it was a good thing for shareholders!
Notice the NASDAQ angle here and the dollar pound exchange rate.

[criticalthinker1] 11/7/2022 22:09

17 March 2022



Midatech Pharma PLC

("Midatech" or the "Company")

Exercise of Warrants and Issue of Equity

Total Voting Rights

Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it has received a notice of exercise of warrants over 26 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at an exercise price of £10.00 per share.

Hmmm

[criticalthinker1] 07/7/2022 21:46

LONDON--Pharmaceutical company Midatech Pharma PLC (MTPH.LN) said Wednesday that it has signed a global licensing agreement with Novartis AG (NOVN.EB) for the oncology compound panobinostat.

The company intends to develop panobinostat for the treatment of brain tumor.

Oncology oncology oncology

Sareum

GSK SIERRA ONCOLOGY BUY OUT APPROVED..OFFICIAL RESULTS TOMORROW. 27.5% stake in SRA737 owned and created by sareum in unison with CRUK.

Stephen Parker BOD of Sareum now at MIDATECH and was previously a vp at GSK

Looking interesting here

[tima441] 07/7/2022 12:37

#Midatech technologies supported by 36 patent families inc 120 granted patents & additional 70 patent applications"
Mkt cap circa £10m with £7m cash!
Multiple shots on goal inc
- #GBM MTX110 under @FDA fast track.
- Q-Sphera partner Janssen $JNJ $460bil [...]

[tima441] 07/7/2022 12:32

UK price inching up to meet US. Gap still over 15%
10.275p UK
12p equivalent US
People cautious after previous spikes not sustained. Perhaps different this time?
Note incremental good newsflow over past year inc trials, FDA, new chairman etc

[criticalthinker1] 06/7/2022 22:29

The recent appointment is not by accident. Great time to buy imo. I'm in. But dyor. Check out links to sareum gsk physiomics and the all intriguing chk1 inhibitor. I think this has legs.

[kingston78] 28/6/2022 08:57

Does anyone know whether this company has sufficient cash this year? The share price is at an all time low. Is the company going to raise funds by way of a placing?

[petersmith6] 10/6/2022 08:46

Intresting possibilities

[manual dexterity] 10/6/2022 07:33

Midatech Pharma PLC
MTX110 Study to be Presented at ISPNO 2022



New Chairman. Same chairman as Sareum Holdings plc.

[petersmith6] 07/6/2022 20:32

When will people learn...Still more news needed before a proper rerate

[dave4545] 07/6/2022 12:28

No investors in this game now, almost 100% day traders looking for a fast buck so they all piled in and then the thought of having to hold is impossible

Traders would rather take a £5-10k loss in a day then hold the stock a few months and get their money back or a profit.

But the RNS did say they are looking to recruit for a phase 1 so I never understood why it spiked so much, like I said there's Bio's well into phase 11 or 111 trials than have little or no support in this market so that rise was never going to last

[kingston78] 07/6/2022 12:07

There was a recent spike to 15 p but now it has come back to square one.